Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: A study of 34 patients

Modern Pathology

Volumn 13, Issue 2, 2000, Pages 123-130

  Goldstein, Neal S ^a   Czako, Peter ^a   Neill, James S ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Capsular invasion; Encapsulated; Follicular carcinoma; Hurthle cell carcinoma; Metastases; Thyroid; Vascular invasion

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; ONCOCYTOMA; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY;

EID: 0033952494     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880023     Document Type: Article

References (80)

1. Woolner LB, Beahrs OH, Black M, McConahey WM, Keating FR Jr. Classification and prognosis of thyroid carcinoma: a study of 885 cases observed in a thirty-year period. Am J Surg 1961;102:354-87.
2. Graham AR. Malignant epithelial tumors of the thyroid with special reference to invasion of blood vessels. Surg Gynecol Obstet 1924;42:781-90.
3. Graham AR. Malignant tumors of the thyroid, epithelial type. Annu Surg 1925;82:30-44.
4. Coller FA. Adenoma and cancer of the thyroid. JAMA 1929; 92:457-62.
5. Warren S. The significance of invasion of blood vessels in adenomas of the thyroid gland. Arch Pathol 1931;11:255-7.
6. Penberton JD. Malignant lesions of the thyroid gland: a review of 774 cases. Surg Gynecol Obstet 1939;417-30.
7. Cole WH, Slaughter DP, Rossiter LJ. Potential dangers of nontoxic nodular goiter. JAMA 1945;127:883-8.
8. Horn RC, Welty RF, Brooks FP, Rhoads JE, Pendergrass EP. Carcinoma of the thyroid. Annu Surg 1947;126:140-55.
9. Hare HF, Salzman FA. Cancer of the thyroid: ten to twenty year follow-up. Am J Roentgenol Radium Ther Nucl Med 1950;63:881-8.
10. Cady B, Sedgwick CE, Meissner WA, Wool MS, Salzman FA, Werber J. Risk factor analysis in differentiated thyroid cancer. Cancer 1979;43:810-20.
11. Franssila KO. Prognosis in thyroid carcinoma. Cancer 1975; 36:1138-46.
12. Frauenhoffer CM, Patchefsky AS, Cobanoglu A. Thyroid carcinoma: a clinical and pathologic study of 125 cases. Cancer 1979;43:2414-21.
13. Arganini M, Behar R, Wu TC, Straus F, McCormick M, DeGroot LJ, et al. Hurthle cell tumors: a twenty-five-year experience. Surgery 1986;100:1108-15.
14. Bronner MP, Livolsi VA. Oxyphilic (Askanazy/Hurthle cell) tumors of the thyroid: microscopic features predict biologic behavior. Surg Pathol 1988;1:137-49.
15. Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J. Follicular Hurthle cell tumors of the thyroid gland. Cancer 1991;68:1944-53.
16. Chen HY, Benjamin LB, Chen MF. Hurthle cell tumor. Int Surg 1996;81:168-70.
17. Flint A, Lloyd RV. Hurthle-cell neoplasms of the thyroid gland. Pathol Annu 1990;25(Pt 1):37-52.
18. Frazell EL, Duffy BJ. Hurthle cell cancer of the thyroid: a review of 40 cases. Cancer 1951;4:952-9.
19. Galera-Davidson H, Bibbo M, Bartels PH, Dytch HE, Puls JH, Wied GL. Correlation between automated DNA ploidy measurements of Hurthle-cell tumors and their histopathologic and clinical features. Anal Quant Cytol Histol 1986;8:158-67.
20. Horn RC. Hurthle cell tumors of the thyroid. Cancer 1954;7: 234-44.
21. Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas: a retrospective follow-up study covering a 14 year period with emphasis on morphological findings. Am J Surg Pathol 1986;10:246-55.
22. McLeod MK, Thompson NW, Hudson JL, Gaglio JA, Lloyd RV, Harness JK, et al. Flow cytometric measurements of nuclear DNA and ploidy analysis in Hurthle cell neoplasms of the thyroid. Arch Surg 1988;123:849-54.
23. Rosai J, Carcangiu ML. Pathology of thyroid tumors: some recent and old questions. Hum Pathol 1984;15:1008-12.
24. Woolner LB. Thyroid carcinoma: pathologic classification with data on prognosis. Semin Nucl Med 1971;1:482-502.
25. Franssila KO. Value of histologic classification of thyroid cancer. Acta Pathol Microbiol Scand 1971; 225A(Suppl):1-76.
26. Lang W, Georgii A, Stauch G, Kienzle E. The differentiation of atypical adenoma and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch Pathol Anat Histopathol 1980A;385:125-41.
27. Kahn NF, Perzin KH. Follicular carcinoma of the thyroid: an evaluation of the histologic criteria used for diagnosis. Pathol Annu 1983;18(Pt 1):221-53.
28. Evans HL. Follicular neoplasms of the thyroid: a study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis. Cancer 1984;54:535-40.
29. Franssila KO, Ackerman LJ, Brown CL, Hedinger CE. Follicular carcinoma. Semin Diagn Pathol 1985;2:101-22.
30. Yamashina M. Follicular neoplasms of the thyroid: total circumferential evaluation of the fibrous capsule. Am J Surg Pathol 1992;16:392-400.
31. Segal K, Arad A, Lubin E, Shpitzer T, Hadar T, Feinmesser R. Follicular carcinoma of the thyroid. Head Neck 1994;16: 533-8.
32. Schmid KW, Totsch M, Ofner D, Bocker W, Ladurner D. Minimally invasive follicular thyroid carcinoma: a clinico-pathological study. Curr Top Pathol 1997;91:37-43.
33. Hazard B, Kenyon R. Encapsulated angioinvasive carcinoma (angioinvasive adenoma) of the thyroid gland. Am J Clin Pathol 1954;24:755-66.
34. Carcangiu ML, Sibley RK, Rosai J. Clear cell change in primary thyroid tumors: a study of 38 cases. Am J Surg Pathol 1985;9:705-22.
35. Clute HM, Smith LW. Cancer of the thyroid gland. Arch Surg 1929;18:1-19.
36. Lahey FW, Hare HF, Warren S. Carcinoma of the thyroid. Annu Surg 1940;112:977-1005.
37. Warren S, Meissner WA. Tumors of the thyroid gland. In: Atlas of tumor pathology (Sect. IV, Fasc. 13). Washington, DC: Armed Forces Institute of Pathology; 1994.
38. Hazard B, Kenyon R. Atypical adenoma of the thyroid. Arch Pathol 1954;58:554-63.
39. Warren S. Invasion of blood vessels in thyroid cancer. Am J Clin Pathol 1956;26:64-5.
40. Horn RC. Problems in the pathologic diagnosis of carcinoma of the thyroid. Arch Pathol 1960;69:481-92.
41. Crile G Jr, Hawk WA. Carcinomas of the thyroid. Cleve Clin Q 1971;38:97-104.
42. Tollefsen HR, Shah JP, Huvos AG. Follicular carcinoma of the thyroid. Am J Surg 1973;126:523-8.
43. Evans HL, Vassilopoulou-Sellin R. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. Am J Surg Pathol 1998;22:1512-20.
44. McKenzie AD. The natural history of thyroid cancer. Arch Surg 1971;102:274-7.
45. Iida F. Surgical significance of capsule invasion of adenoma of the thyroid. Surg Gynecol Obstet 1977;144:710-2.
46. Silverberg SG, Vidone RA. Adenoma and carcinoma of the thyroid. Cancer 1966;19:1052-62.
47. Gosain AK, Clark OH. Hurthle cell neoplasms. Arch Surg 1984;119:515-9.
48. Saull SC, Kimmelman CP. Hurthle cell tumors of the thyroid gland. Otolaryngol Head Neck Surg 1985;93:58-62.
49. Heppe H, Armin A, Calandra DB, Lawrence AM, Paloyan E. Hurthle cell tumors of the thyroid gland. Surgery 1985;98: 1162-5.
50. Fukunaga M, Shinozaki N, Endo Y, Ushigome S. Atypical adenoma of the thyroid: a clinicopathologic and flow cytometric DNA study in comparison with other follicular neoplasms. Acta Pathol Jpn 1992;42:632-8.
51. Lin KD, Lin JD, Huang MJ, Huang HS, Jeng LB, Chao TC, et al. Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int Surg 1997;82: 378-81.
52. Farahati J, Bucsky P, Parlowsky T, Mader U, Reiners C. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer 1997;80:2156-62.
53. Bondeson L, Bondeson AG, Ljungberg O, Tibblin S. Oxyphil tumors of the thyroid: follow-up of 42 surgical cases. Annu Surg 1981;194:677-80.
54. Gardner LW. Hurthle cell tumors of the thyroid. Arch Pathol 1955;59:372-81.
55. Miller RH, Estrada R, Sneed WF, Mace ML. Hurthle cell tumors of the thyroid gland. Laryngoscope 1983;93:884-8.
56. Caplan RH, Abellera RM, Kisken WA. Hurthle cell tumors of the thyroid gland: a clinicopathologic review and long-term follow-up. JAMA 1984;251:3114-7.
57. Akslen LA, Myking AO. Differentiated thyroid carcinomas: the relevance of various pathological features for tumor classification and prediction of tumor progress. Virchows Arch [A] Pathol Anat Histopathol 1992;421:17-23.
58. Zimmermann LM, Wagner DH, Perlmutter HM, Amromin GD. Benign and malignant epithelial tumors of the thyroid gland. Arch Surg 1950;60:1183-98.
59. Chesky VE, Dreese WC, Hellwig CA. Hurthle cell tumors of the thyroid gland: report on 25 cases. J Clin Endocrinol Metab 1951;11:1535-49.
60. Blum M, Feiner HD, Worth MH, King LW. Clinical implications of the rare thyroid carcinoma which is indistinguishable from a follicular adenoma. Am J Med Sci 1978;276:99-104.
61. Crile G Jr, Pontius KI, Hawk WA. Factors influencing the survival of patients with follicular carcinoma of the thyroid gland. Surg Gynecol Obstet 1985;160:409-13.
62. Donohue JH, Goldfien SD, Miller TR, Abele JS, Clark OH. Do the prognoses of papillary and follicular thyroid carcinomas differ? Am J Surg 1984;148:168-73.
63. Schroder S, Pfannschmidt N, Dralle H, Arps H, Bocker W. The encapsulated follicular carcinoma of the thyroid: a clinicopathologic study of 35 cases. Virchows Arch [A] Pathol Anat Histopathol 1984;402:259-73.
64. DeGroot LJ, Kaplan EL, Shukla MS, Salti G, Straus FH. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 1995;80:2946-53.
65. Jorda M, Gonzalez-Campora R, Herrero-Zapatero A, Otal C, Galera H. Prognostic factors in follicular carcinoma of the thyroid. Arch Pathol Lab Med 1993;117:631-5.
66. Emerick GT, Duh QY, Siperstein AE, Burrow GN, Clark OH. Diagnosis, treatment, and outcome of follicular thyroid carcinoma [see comments]. Cancer 1993;72:3287-95.
67. Hirabayashi RN, Lindsay S. Carcinomas of the thyroid gland: a statistical study of 390 patients. J Endocrinol Metab 1961; 21:1596-610.
68. Har-El G, Hadar T, Segal K, Levy R, Sidi J. Hurthle cell carcinoma of the thyroid gland: a tumor of moderate malignancy. Cancer 1986;57:1613-7.
69. Samaan NA, Maheshwari YK, Nader S, Hill CSJ, Schultz PN, Haynie TP, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 1983;56:1131-8.
70. Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG. Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med 1980;21:733-7.
71. Johannessen JV, Sobrinho-Simoes M. Follicular carcinoma of the human thyroid gland: an ultrastructural study with emphasis on scanning electron microscopy. Diag Histopathol 1982;5:113-27.
72. Gonzalez-Campora R, Herrero-Zapatero A, Lerma E, Sanchez F, Galera H. Hurthle cell and mitochondrion-rich cell tumors: a clinicopathologic study. Cancer 1986;57:1154-63.
73. Selzer G, Kahn LB, Albertyn L. Primary malignant tumors of the thyroid gland: a clinicopathologic study of 254 cases. Cancer 1977;40:1501-10.
74. Cady B, Sedgwick CE, Meissner WA, Bookwalter JR, Romagosa V, Werber J. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Annu Surg 1976;184:541-53.
75. Gundry SR, Burney RE, Thompson NW, Lloyd RV. Total thyroidectomy for Hurthle cell neoplasm of the thyroid. Arch Surg 1983;118:529-32.
76. Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH. Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet 1974;139:555-60.
77. Watson RG, Brennan MD, Goellner JR, van Heerden JA, McConahey WM, Taylor WF. Invasive Hurthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc 1984;59:851-5.
78. Lin JD, Huang HS, Chen SC, Chao TC. Factors that predict metastasis of papillary and follicular thyroid cancers in Taiwan. Otolaryngol Head Neck Surg 1997;116:475-82.
79. Segal K, Raveh E, Lubin E, Abraham A, Shvero J, Feinmesser R. Well-differentiated thyroid carcinoma. Am J Otolaryngol 1996;17:401-6.
80. Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 1996;172:692-4.